Accession Number: | 0001209191-21-044977 |
Date: | 2021-06-30 |
Issuer: | VYNE THERAPEUTICS INC. (VYNE) |
Original Submission Date: |
HARSCH MUTYA
520 U.S. HIGHWAY 22, SUITE 204
BRIDGEWATER, NJ 08807
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-06-30 | F | 3,551 | d | $3.51 | 105,322 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | represents shares that have been withheld by the issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |